Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 4, 2009, Pages

  Cheng, Jingfei ^a   Zhou, Wei ^a   Warner, Gina M ^a   Knudsen, Bruce E ^a   Garovic, Vesna D ^a   Gray, Catherine E ^a   Lerman, Lilach O ^a   Platt, Jeffrey L ^a,b   Romero, J Carlos ^a   Textor, Stephen C ^a   Nath, Karl A ^a   Grande, Joseph P ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Atrophy; Fibrosis; Hypertrophy hyperplasia; Inflammation; Renal artery stenosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL NUCLEUS ANTIGEN; CYCLINE; KI 67 ANTIGEN; MARKER; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; BODY WEIGHT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; HISTOPATHOLOGY; HYPERTENSION; INFLAMMATION; KIDNEY; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY SIZE; KIDNEY TUBULE; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 70349633460     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90439.2008     Document Type: Article

References (41)

1. Bokemeyer D, Panek D, Kramer HJ, Lindemann M, Kitahara M, Boor P, Kerjaschki D, Trzaskos JM, Floege J, Ostendorf T. In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13: 1473-1480, 2002. (Pubitemid 34579236)
2. Cheng J, Grande J. Transforming growth factor-beta and kidney dysfunction. J Organ Dysfunction. In press.
3. Cheng J, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 227: 943-956, 2002. (Pubitemid 36008302)
4. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984.
5. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70, 2003. (Pubitemid 36135887)
6. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson RJ. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 7: 177-185, 1994. (Pubitemid 24079128)
7. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996. (Pubitemid 26008141)
8. Grande J, Melder D, Zinsmeister A, Killen P. TGF-β1 induces collagen IV gene expression in NIH-3T3 cells. Lab Invest 69: 387-395, 1993.
9. Grande JP, Melder DC, Zinsmeister AR. Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-β1, with divergent effects of epidermal growth factor and tumor necrosis factor-α on collagen type I and collagen type IV. J Lab Clin Med 130: 476-486, 1997.
10. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36: 443-451, 2002.
11. Hayashida T, Poncelet AC, Hubchak S, HWS. TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 56: 1710-1720, 1999. (Pubitemid 29518171)
12. -/- HCT116 colon cancer cells. DNA Repair (Amst) 7: 239-252, 2008.
13. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 103: 597-604, 1999. (Pubitemid 29122412)
14. Hocher B, Godes M, Olivier J, Weil J, Eschenhagen T, Slowinski T, Neumayer HH, Bauer C, Paul M, Pinto YM. Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension. J Hypertens 20: 745-751, 2002. (Pubitemid 34913720)
15. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 6: 407-413, 2007. (Pubitemid 46393442)
16. Jo SK, Cho WY, Sung SA, Kim HK, Won NH. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 67: 458-466, 2005.
17. Jones ML, Warren JS. Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis. Lab Invest 66: 498-503, 1992.
18. Lazartigues E, Lawrence AJ, Lamb FS, Davisson RL. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res 95: 523-531, 2004. (Pubitemid 39193248)
19. Li CY, Suardet L, Little JB. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 270: 4971-4974, 1995.
20. Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY. Advanced glycation end products induce tubular epithelialmyofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 164: 1389-1397, 2004. (Pubitemid 38387804)
21. Liu B, Preisig PA. Compensatory renal hypertrophy is mediated by a cell cycle-dependent mechanism. Kidney Int 62: 1650-1658, 2002. (Pubitemid 35286272)
22. Lowry O, Rosebrough A, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
23. Luo Y, Hurwitz J, Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161, 1995.
24. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 17: 707-719, 1991.
25. Masaki T, Stambe C, Hill PA, Dowling J, Atkins RC, Nikolic-Paterson DJ. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol 15: 1835-1843, 2004.
26. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 580: 2811-2820, 2006.
27. Moskowitz DW, Liu W. Gene expression after uninephrectomy in the rat: simultaneous expression of positive and negative growth control elements. J Urol 154: 1560-1565, 1995.
28. Nath K, Vercellotti G, Grande J, Miyoshi H, Paya C, Manivel J, Haggard J, Croatt A, Payne W, Alam J. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 59: 106-117, 2001. (Pubitemid 32055219)
29. Nath KA, Grande JP, Croatt A, Haugen J, Kim Y, Rosenberg ME. Redox regulation of renal DNA synthesis, TGF-β1 and collagen gene expression. Kidney Int 53: 367-381, 1998.
30. Nath KA, Salahudeen AK, Clark EC, Hostetter MK, Hostetter TH. Role of cellular metabolites in progressive renal injury. Kidney Int Suppl 38: S109-S113, 1992.
31. Kip1 safeguards against inflammatory injury. Nat Med 4: 575-580, 1998.
32. Terzi F, Ticozzi C, Burtin M, Motel V, Beaufils H, Laouari D, Assael BM, Kleinknecht C. Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression. Am J Physiol Renal Fluid Electrolyte Physiol 268: F793-F801, 1995.
33. Textor SC. Managing renal arterial disease and hypertension. Curr Opin Cardiol 18: 260-267, 2003.
34. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 52: 421-442, 2001.
35. Thone-Reineke C, Olivier J, Godes M, Zart R, George I, Bauer C, Neumayer HH, Hocher B. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension. Clin Sci (Lond) 104: 79-85, 2003. (Pubitemid 36249926)
36. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994. (Pubitemid 24228301)
37. Tracz M, Juncos J, Croatt A, Ackerman A, Grande J, Knutson K, Kane G, Terzic A, Griffin M, Nath K. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007. (Pubitemid 47609038)
38. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994. (Pubitemid 24192528)
39. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29: 1025-1030, 1997. (Pubitemid 27152476)
40. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6: 603-610, 2004. (Pubitemid 39411098)
41. Yang M, Huang H, Li J, Li D, Wang H. Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J 18: 1920-1921, 2004.